Clinical Trials Browser

Phase 2/3 × Ovarian Neoplasms × Drug Therapy × Clear all

NCT04795596 2022-04-15

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Phase 2/3 Withdrawn

Ovarian Neoplasms

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Phase 2/3 Completed

BreastGynecologicSarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma